TNPSC Thervupettagam

Bacterial Infections in India in 2019

May 6 , 2025 17 hrs 0 min 13 0
  • Only eight per cent of bacterial infections reported in India in 2019 were treated appropriately.
  • Nearly 15 lakh bacterial infections were resistant to carbapenems in eight countries where the study was conducted.
  • Carbapenems is a common antibiotic agent used to treat very severe bacterial infections.
  • India procured most of the treatment courses (80.5 per cent; 83,468 courses), with 7.8 per cent of infections treated appropriately.
  • Nearly 1.1 million deaths annually are a direct result of AMR.
  • This is more than the combined deaths from HIV/AIDS and malaria in 2022.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories